SARS-CoV-2-Induced PAPOLG Contributes to Inflammation Response by Stabilizing NF-κB mRNA.

Publication date: Jul 01, 2025

One of the unknowns related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the mechanism underlying the inflammatory response induced by the virus. Poly(A) polymerase gamma (PAPOLG) was previously shown to be upregulated during SARS-CoV-2 infection. The present study explored how PAPOLG affects the inflammatory reaction triggered by SARS-CoV-2. PAPOLG was knocked down or overexpressed in THP-1 macrophages. Target pathways were identified using RNA sequencing and bioinformatics analysis. The levels of PAPOLG, transcriptional regulator nuclear factor kappa-light-chain-enhancer of activated B cells (NF-_705B), and cytokines TNF-α and IL-6 were measured, along with an assessment of NF-_705B mRNA stability. PAPOLG was significantly upregulated in SARS-CoV-2-infected THP-1 macrophages. Genes subjected to alternative polyadenylation were enriched in immune pathways, and NF-_705B emerged as a key regulator. Knockdown of PAPOLG promoted NF-_705B mRNA degradation, while decreasing the levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL6). Conversely, overexpression of PAPOLG stabilized NF-_705B mRNA and enhanced TNF-α and IL-6 expression. PAPOLG contributes to the inflammatory response in SARS-CoV-2-infected macrophages by stabilizing NF-_705B mRNA. Thus, PAPOLG may be targeted to control COVID-19-related inflammation.

Concepts Keywords
Coronavirus COVID-19
Kappa cytokine storm
Mrna Humans
Necrosis IL6 protein, human
Stabilizing Inflammation
inflammation
Interleukin-6
Interleukin-6
Macrophages
NF-kappa B
NF-kappa B
NF‐κB
PAPOLG
Polynucleotide Adenylyltransferase
Polynucleotide Adenylyltransferase
RNA Stability
RNA, Messenger
RNA, Messenger
SARS-CoV-2
SARS‐CoV‐2
THP-1 Cells
Tumor Necrosis Factor-alpha
Tumor Necrosis Factor-alpha

Semantics

Type Source Name
disease MESH Inflammation
disease MESH infection
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH cytokine storm

Original Article

(Visited 1 times, 1 visits today)